Breakthrough in Genetic Disorder Treatment: GC Pharma’s Sanfilippo Syndrome Drug Receives FDA Phase 1 Approval

Sanfilippo,GC Pharma,Regulatory,Treatment,Regulatory

[su_heading size=”27″ align=”left” margin=”40″]Introduction to Sanfilippo Syndrome and GC Pharma’s Efforts[/su_heading] Sanfilippo Syndrome, also known as Mucopolysaccharidosis Type III, is a rare genetic disorder caused by the body’s inability to produce an enzyme necessary for breaking down heparan sulfate. This accumulation leads to severe organ damage and developmental delays. GC Pharma, in collaboration with biotech … Read more

Meet the Pioneers Redefining the Space Industry: Join the SpaceK 2024 Forum in Seoul

Space,SpaceK 2024,korea,healthcare

[su_heading size=”27″ align=”left” margin=”40″]Introduction to SpaceK 2024[/su_heading] On June 5th, Chosun Biz, the economic media arm of the Chosun Media Group, will host the inaugural SpaceK 2024 forum at the Korean Federation of Science and Technology Societies in Gangnam, Seoul. This event aims to highlight the visionary minds driving the new era of space exploration … Read more

The Importance of Early Retinal Screening for Newborns: Preventing Childhood Blindness

Retinal,Diseases,Yejoon,Advocacy,Congenital

[su_heading size=”27″ align=”left” margin=”40″]Understanding Congenital Retinal Diseases[/su_heading] Congenital retinal diseases, such as Familial Exudative Vitreoretinopathy (FEVR), are conditions that can lead to severe vision impairment or even blindness in newborns. These diseases are often undetectable without specific screening, such as the retinal screening (fundus examination) that is not commonly included in standard neonatal check-ups. [su_heading … Read more